Parkinson's disease (PD) manifests with a typical movement disorder, due to the loss of
dopaminergic neurons of the substantia nigra. There are no disease-modifying treatments …

Parkinson's disease (PD) is a common, progressive neurodegenerative disorder
characterized by substantia nigra dopamine cell death and a varied clinical picture that …

Current findings suggest that multipotent stem cells may be suitable for cell replacement
therapies in the treatment of neurodegenerative disorders. Embryonic stem (ES) cells are …

Parkinson's disease (PD) is the second most common neurodegenerative disorder after
Alzheimer's disease and it is characterized by the progressive loss of dopaminergic neurons …

Parkinson's disease (PD) is one of the most frequent neurodegenerative diseases and
represents a major therapeutic challenge because of the so far missing therapeutic means …

Currently the mainstay of Parkinson's disease (PD) therapy is the pharmacological
replacement of the loss of the dopaminergic nigrostriatal pathway using drugs such as …

Background: Cell transplantation to replace lost neurons in neurodegenerative diseases
such as Parkinson's disease (PD) offers a hopeful prospect for many patients. Previously …

Motor djsfunctions in Parkinson's disease a· e believed to be primarily due to the
degeneration of dopamincrgic neurons located in the substantia nigra pars compacta …

Cell replacement therapies in Parkinson's disease (PD) aim to provide long-lasting relief of
patients' symptoms. Previous clinical trials using transplantation of human fetal ventral …

Parkinson's disease (PD) is the most common movement disorder. The neuropathology is
characterized by the loss of dopamine neurons in the substantia nigra pars compacta …